FIELD: chemistry.
SUBSTANCE: present invention relates to an imidazo[1,2-a]pyridine derivative of general formula I, having inhibitory activity on gastric acid secretion, a pharmaceutical composition based thereon, method of treatment and use for treating a disease caused by excessive secretion of gastric acid. In general formula IY1, Y2 and Y3, each, independently, is H, halogen, straight-chain C1-C6 alkyl, unsubstituted or substituted with R1 or hydroxy; R1 is hydroxy; Y4 represents H, C1-C6 straight chain alkyl or C1-C6 alkoxy; and X is H or halogen.
EFFECT: treatment of the disease caused by excessive secretion of gastric acid.
10 cl, 1 dwg, 4 tbl, 48 ex
Title | Year | Author | Number |
---|---|---|---|
HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2015 |
|
RU2711502C2 |
HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2015 |
|
RU2734390C2 |
HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2014 |
|
RU2681849C2 |
DERIVATIVES OF IMIDAZO[1,2-A]PYRIDINE, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL PREPARATION BASED ON THEREOF, METHOD OF INHIBITION OF GASTRIC ACID SECRETION, METHOD OF TREATMENT OF GASTROENTERIC INFLAMMATORY DISEASES AND METHOD OF TREATMENT OF STATES WITH HELICOBACTER PYLORI INFECTION | 1998 |
|
RU2193036C2 |
PYRROLO[2,3-c]PYRIDINE DERIVATIVES AND METHOD OF PRODUCING SAID DERIVATIVES | 2005 |
|
RU2385320C2 |
NOVEL TRICYCLIC DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SAID DERIVATIVE | 2009 |
|
RU2470934C1 |
BIARYL DERIVATIVE AS GPR120 AGONIST | 2015 |
|
RU2683648C2 |
PYRROLO-PYRIDINE COMPOUND DERIVATIVE, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING AND TREATING PROTEIN KINASE RELATED DISEASES | 2018 |
|
RU2730849C1 |
HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | 2016 |
|
RU2710743C2 |
DERIVATIVES OF IMIDAZOPYRIDINE, METHOD FOR THEIR PREPARING AND INTERMEDIATE COMPOUNDS, PHARMACEUTICAL PREPARATION BASED ON THEREOF (VARIANTS), METHOD FOR INHIBITION OF GASTRIC ACID SECRETION AND METHOD FOR TREATMENT OF STATES ASSOCIATED WITH HELICOBACTER PYLORI INFECTION | 1999 |
|
RU2235725C2 |
Authors
Dates
2020-06-30—Published
2017-07-04—Filed